Indian-American Doctor Thirumala-Devi Kanneganti Finds Possible Treatment To Prevent COVID-19 Deaths

| |

Indian-American Doctor Identifies Possible Treatment To Prevent COVID-19 Deaths

Indian-American physician Thirumala-Devi Kanneganti finds attainable remedy to forestall covid deaths


An Indian-American physician and scientist has found a possible technique to forestall life-threatening irritation, lung harm and organ failure in sufferers identified with COVID-19.

Printed on-line within the journal Cell, the analysis coming from the lab of Dr Thirumala-Devi Kanneganti, an Indian-born researcher working at St. Jude Youngsters’s Analysis Hospital in Tennessee, recognized the medicine after discovering that the hyperinflammatory immune response related to COVID-19 results in tissue harm and multi-organ failure in mice by triggering inflammatory cell demise pathways.

The researchers detailed how the inflammatory cell demise signaling pathway labored, which led to potential therapies to disrupt the method.

“Understanding the pathways and mechanism driving this irritation is vital to develop efficient remedy methods,” stated Dr Kanneganti, vice chair of the St Jude Division of Immunology.

Dr Kanneganti was born and raised in Telangana. She acquired her undergraduate diploma at Kakatiya College in Warangal, the place she majored in Chemistry, Zoology, and Botany. She then acquired her M.Sc. and Ph.D from Osmania College in India. She joined St. Jude, in Memphis, Tennessee, USA, in 2007.

“This analysis gives that understanding. We additionally recognized the particular cytokines that activate inflammatory cell demise pathways and have appreciable potential for remedy of COVID-19 and different extremely deadly illnesses, together with sepsis,” she stated.

The opposite researchers have been Shraddha Tuladhar, Parimal Samir, Min Zheng, Balamurugan Sundaram, Balaji Banoth, RK Subbarao Malireddi, Patrick Schreiner, Geoffrey Neale, Peter Vogel and Richard Webby, of St. Jude; and Evan Peter Williams, Lillian Zalduondo and Colleen Beth Jonsson, of the College of Tennessee Well being Science Middle.

COVID-19 is brought on by the SARS-CoV-2 virus. The an infection has killed greater than 1.2 million individuals in lower than one 12 months and sickened tens of millions extra.

The an infection is marked by elevated blood ranges of a number of cytokines. These small proteins are secreted primarily by immune cells to make sure a speedy response to limit the virus. Some cytokines additionally set off irritation.


The phrase cytokine storm has been used to explain the dramatically elevated cytokine ranges within the blood and different immune modifications which have additionally been noticed in COVID-19, sepsis and inflammatory issues resembling hemophagocytic lymphohistiocytosis (HLH), St Jude’s stated in an announcement.

However the particular pathways that provoke the cytokine storm and the following irritation, lung harm and organ failure in COVID-19 and the opposite issues have been unclear.

The mobile and molecular mechanisms that comprehensively outline cytokine storm was additionally missing. Dr Kanneganti’s crew targeted on a choose set of essentially the most elevated cytokines in COVID-19 sufferers. The scientists confirmed that no single cytokine induced cell demise in innate immune cells, it stated.

“The findings hyperlink inflammatory cell demise induced by TNF-alpha and IFN-gamma to COVID-19, Dr Kanneganti stated.

“The outcomes additionally counsel that therapies that focus on this cytokine mixture are candidates for speedy scientific trials for remedy of not solely COVID-19, however a number of different typically deadly issues related to cytokine storm,” she stated.

“We have been excited to attach these dots to know how TNF-alpha and IFN-gamma set off PANoptosis,” stated co-first writer Rajendra Karki, a scientist within the Kanneganti laboratory.

“Certainly, understanding how PANoptosis contributes to illness and mortality is vital for figuring out therapies,” added co-first writer Bhesh Raj Sharma, a scientist within the Kanneganti laboratory.

(Apart from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)


Harley-Davidson To Continue India Operations January 2021 Onwards

Probe Agency ED Files Money Laundering Case In Fake TV Ratings Scam


Leave a Comment